Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 7.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo, Richard S. Finn, Shukui Qin et al. · The Lancet · 2018 · 5.4K citations · Full text

Medicine, Oncology, Pharmacology +12

Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma

Junichi Shindoh, Yusuke Kawamura, Yuta Kobayashi et al. · Annals of Surgical Oncology · 2021 · 87 citations

Medicine, Oncology, Surgery +17

Impact of tumor size, number of tumors and neutrophil‐to‐lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma

Tomoharu Yoshizumi, Toru Ikegami, Shohei Yoshiya et al. · Hepatology Research · 2012 · 83 citations

Medicine, Oncology, Surgery +16

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience

Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada et al. · Cancer Reports · 2021 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +17